These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25022254)

  • 1. Impact of comorbidity on survival after palliative radiotherapy.
    Nieder C; Engljähringer K; Angelo K
    Strahlenther Onkol; 2014 Nov; 190(12):1149-53. PubMed ID: 25022254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after palliative radiotherapy in geriatric cancer patients.
    Nieder C; Angelo K; Haukland E; Pawinski A
    Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance.
    Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
    Int J Circumpolar Health; 2017; 76(1):1270080. PubMed ID: 28452680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy of the oldest old-feasibility and institutional analysis.
    Kretschmer EM; Pavic M; Stark LS; Hertler C; Guckenberger M
    Strahlenther Onkol; 2020 Aug; 196(8):683-690. PubMed ID: 32367454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models.
    Nieder C; Kämpe TA
    Anticancer Res; 2018 Mar; 38(3):1705-1709. PubMed ID: 29491105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing access to palliative radiotherapy: a Norwegian population-based study.
    Åsli LM; Myklebust TÅ; Kvaløy SO; Jetne V; Møller B; Levernes SG; Johannesen TB
    Acta Oncol; 2018 Sep; 57(9):1250-1258. PubMed ID: 29706109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
    Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH
    Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale".
    Kos FT; Yazici O; Civelek B; Seker M; Arik Z; Aksoy S; Uncu D; Ozdemir N; Zengin N
    Wien Klin Wochenschr; 2014 Jan; 126(1-2):36-41. PubMed ID: 24249323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative radiotherapy in patients with a poor performance status: the palliative effect is correlated with prolongation of the survival time.
    Yamaguchi S; Ohguri T; Matsuki Y; Yahara K; Narisada H; Imada H; Korogi Y
    Radiat Oncol; 2013 Jul; 8():166. PubMed ID: 23829540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: a retrospective analysis of 303 patients.
    Rief H; Muley T; Bruckner T; Welzel T; Rieken S; Bischof M; Lindel K; Combs SE; Debus J
    Strahlenther Onkol; 2014 Jan; 190(1):59-63. PubMed ID: 24052009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy.
    Caparrotti F; O'Sullivan B; Bratman SV; Ringash J; Lu L; Bayley A; Cho J; Giuliani M; Hope A; Kim J; Waldron J; Hansen A; Goldstein D; Perez-Ordonez B; Weinreb I; Tong L; Song Y; Xu W; Huang SH
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):858-867. PubMed ID: 28258893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Radiation Therapy Within the Last Year of Life Among Cancer Patients.
    Tseng YD; Gouwens NW; Lo SS; Halasz LM; Spady P; Mezheritsky I; Loggers E
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):21-29. PubMed ID: 29487025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy in Older Patients ≥70 Years Receiving Palliative Radiotherapy.
    Nieder C; Mannsăker B; Pawinski A; Haukland E
    Anticancer Res; 2017 Feb; 37(2):795-799. PubMed ID: 28179332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thirty-day mortality after palliative radiotherapy in advanced cancer patients: Optimizing end-of-life care in Asia.
    Kim MS; Cha H; You SH; Kim S
    J Med Imaging Radiat Oncol; 2024 Apr; 68(3):307-315. PubMed ID: 38450953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
    Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
    Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metastasis from non-small cell lung cancer (NSCLC): prognostic importance of the number of involved extracranial organs.
    Gerdan L; Segedin B; Nagy V; Khoa MT; Trang NT; Schild SE; Rades D
    Strahlenther Onkol; 2014 Jan; 190(1):64-7. PubMed ID: 24104871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal hypofractionated conformal radiotherapy for large brain metastases in patients with high risk factors: a single-institutional prospective study.
    Inoue HK; Sato H; Suzuki Y; Saitoh J; Noda SE; Seto K; Torikai K; Sakurai H; Nakano T
    Radiat Oncol; 2014 Oct; 9():231. PubMed ID: 25322826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and Characteristics of Patients Treated with Emergent Palliative Radiation Therapy.
    Grade M; Koenig J; Qian Y; Sandhu N; Liu Y; Turner B; von Eyben R; Knox S; Dudley S
    Pract Radiat Oncol; 2019 Mar; 9(2):e203-e209. PubMed ID: 30529795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer.
    van Oorschot B; Assenbrunner B; Schuler M; Beckmann G; Flentje M
    Strahlenther Onkol; 2014 Mar; 190(3):270-5. PubMed ID: 24413894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
    Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
    BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.